-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Atezolizumab in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Atezolizumab in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atezolizumab in Follicular Lymphoma Drug Details: Atezolizumab (Tecentriq) is an antineoplastic agent....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabectedin in Ewing Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Ewing Sarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabectedin in Ewing Sarcoma Drug Details: Trabectedin (Yondelis) is an anti tumor...
-
Product Insights
NewBasal Cell Carcinoma (Basal Cell Epithelioma) – Drugs In Development, 2024
Empower your strategies with our Basal Cell Carcinoma (Basal Cell Epithelioma) – Drugs In Development, 2024 report and make more profitable business decisions. Basal cell carcinoma is a type of skin cancer which begins in the basal cells. Symptoms include a waxy bump; a scaly, brown, or flesh-colored patch; or a white, waxy scar. Predisposing factors include age, family history, and exposure to radiation and immunosuppressant medications. Treatment includes chemotherapy and surgery. The Basal Cell Carcinoma (Basal Cell Epithelioma) drugs in...
-
Product Insights
NewChronic Urticaria Or Hives – Drugs In Development, 2024
Empower your strategies with our Chronic Urticaria Or Hives – Drugs In Development, 2024 report and make more profitable business decisions. Chronic urticaria, also known as hives, are outbreaks of swollen, pale red bumps, patches, or welts on the skin that appear suddenly either as a result of allergies, or for other reasons. The main symptom is itchy rashes. Chronic urticaria occurs when histamine and other chemicals are released from under the skin's surface, causing the tissues to swell. Predisposing factors...
-
Product Insights
NewAlopecia – Drugs In Development, 2024
Empower your strategies with our Alopecia – Drugs In Development, 2024 report and make more profitable business decisions. Alopecia is the partial or complete loss of hair, especially on the scalp; it can occur in patches, on the entire head, or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, exposure to irritants or toxins, burns, injuries, and infections. The Alopecia drugs in development market research report provide comprehensive information on the therapeutics under...
-
Product Insights
NewPlaque Psoriasis (Psoriasis Vulgaris) – Drugs In Development, 2024
Empower your strategies with our Plaque Psoriasis (Psoriasis Vulgaris) – Drugs In Development, 2024 report and make more profitable business decisions. Plaque psoriasis, also known as psoriasis vulgaris, is the most common form of psoriasis, a chronic skin condition characterized by the rapid buildup of skin cells. It results from an overactive immune system, causing skin cells to accumulate on the surface, forming thick, scaly, and often itchy patches or plaques. These patches can vary in size and typically have a...
-
Product Insights
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Overview The Plaque Psoriasis (Psoriasis Vulgaris) clinical trial report consists of 2018 trials. The report provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) clinical trial scenario. Our study also includes top-line data relating to the clinical trials on Plaque Psoriasis (Psoriasis Vulgaris). Our analysts have further provided an overview of trial numbers and their average enrolment in top countries conducted across the globe, in this report. Furthermore, our review of the Plaque Psoriasis...
-
Product Insights
Rangapuram Mine
The Rangapuram Mine is a iron ore mine in India. It is currently in operation. Empower your strategies with our Rangapuram Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UNI-50002 in Atopic Dermatitis (Atopic Eczema)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.UNI-50002 in Atopic Dermatitis (Atopic Eczema)Drug Details:Orismilast (UNI-50002 and LEO 32731) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olorinab in Abdominal Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olorinab in Abdominal Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Olorinab in Abdominal PainDrug Details:Olorinab (APD-371) is under development for the treatment of...